Is PBPK useful to inform product label on managing clinically significant drug interactions mediated by cytokine release syndrome?
CPT Pharmacometrics Syst Pharmacol
.
2024 Jul;13(7):1083-1087.
doi: 10.1002/psp4.13185.
Epub 2024 Jun 12.
Authors
Xinyuan Zhang
1
,
Ping Zhao
2
Affiliations
1
Quantitative Clinical Pharmacology, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
2
Bill & Melinda Gates Foundation, Seattle, Washington, USA.
PMID:
38866079
PMCID:
PMC11247104
DOI:
10.1002/psp4.13185
No abstract available
Publication types
Editorial
MeSH terms
Cytokine Release Syndrome* / drug therapy
Drug Interactions*
Drug Labeling
Humans
Models, Biological